Primus In News
Push for health care: BCD exemption for lifesaving drugs, additional medical seats and more in Budget 2025
01-02-2025
Nilaya Varma, Co-Founder and CEO, Primus Partners, stated that the government's move to reduce customs duties on life-saving drugs is a much-needed measure to help the middle class access critical treatments for life-threatening conditions.
Explore Related Insights
- Flipkart Group-owned Myntra revises commission structure to drive low-ticket sales
- Unleashing potential: the vibrant landscape of innovation and entrepreneurship in India's tier 2 and tier 3 cities
- ProcMart just levelled up: This Noida start-up expands empire with latest packaging facility grab
- Foxconn junks Rs 1.61 lakh crore Vedanta chip plan, Vedanta says other investors lined up